Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease | American Society of Nephrology
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients - Kidney International Reports
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Serum Free Light Chain Assay - Renal Fellow Network
Manni Mohyuddin on Twitter: "Well- Normally kappa FLC are produced more often than lambda.. BUT lambda more frequently forms dimers, which doubles their molecular weight and slows their renal clearance..." / Twitter
Physiology of serum free light chains - Renal Fellow Network
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Comparison of Free Light Chain Removal by Four Blood Purification Methods - Kanayama - 2011 - Therapeutic Apheresis and Dialysis - Wiley Online Library
Removal of free light chains in hemodialysis patients without multiple myeloma: a crossover comparison of three different dialyzers | BMC Nephrology | Full Text
Serum Free Light Chains and the Risk of ESRD and Death in CKD Article
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy | PLOS ONE
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Correspondence data for kappa and lambda free light chain analysis | Download Table
![PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table4-1.png "PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar")
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
Time course of serum creatinine and free light chains lambda for... | Download Scientific Diagram
